Mar 14, 2013

Hepatitis B Vaccine Damages the Liver

Via: EV
The predictive programming presstitutes continually want you to believe that vaccines have saved more lives than any other form of human intervention. The Manchurian media quote the phrase medical miracle over and over again until you believe that vaccines have truly saved the world. When looking deeper down the rabbit hole of subterfuge you begin to find a completely different story unfolds. One of the statistics that rises to the surface of this gurgling cesspool is that the lion's share of all the outbreaks sensationalized by the manchurian mainstream mediots involve vaccinated people.
 A new study conducted by the National Institute of Death indicates the aluminum hydroxide adjuvants added to the vaccine is causing liver damage and increasing the risk of hepatitis in adults. The study was done because of an incident back in 2012 where the police abducted Jodi Ferriss's newborn when she questioned the need for the hepatitis B vaccination. The pharmacratical dictators seek to poison you with their snake oil medications and vaccinations designed to create a constant stream of customers by turning people in the patients one prescription at a time.
Welcome to a brave new world.

Via: TheHealthyHomeEconomist
When Jodi Ferris unknowingly unleashed the wrath of Social Services at Penn State Hershey Medical Center by questioning the necessity of the Hepatitis B vaccine for her newborn daughter, little did she know just how big a can of worms she was opening.

A study reported in the journal Apoptosis just weeks ago indicates that this controversial vaccine normally injected into newborns within hours of birth induces liver damage primarily due to the presence of the toxic vaccine adjuvant aluminum hydroxide.

Aluminum hydroxide, an adjuvant also present in the anthrax vaccine, has already been shown as a likely culprit for triggering the motor neuron autoimmunity issues present in Gulf War Syndrome which are indistinguishable from the autoimmune disease amyotrophic lateral sclerosis (ALS).

Vaccine adjuvants like aluminum hydroxide are the dirty little secret that the scientific community doesn’t want the public to know about.  Their purpose is to stimulate and heighten the immune response to the vaccine itself.

In this new study, aluminum hydroxide induced loss of mitochondrial integrity and cell death in mouse liver cells exposed to low doses of the Hepatitis B vaccine containing the toxic adjuvant.

The mitochondria is the “powerhouse” of a cell where energy is created and cellular respiration occurs.  It is not surprising that compromising the mitochondria of liver cells results in outright death of the cell itself.

This new study corroborates other research indicating liver damage from Hep B.  In 1999, it was found that children less than 6 years old had a nearly 300% increase in the incidence of liver problems if they had been vaccinated with Hepatitis B versus those children that did not have the Hep B jab.

It’s not just the young developing livers of children that suffer from the toxic Hep B.   The Journal Hepatogastroenterology reported in 2002 that the Hepatitis B vaccine was statistically associated with increased risk for hepatitis, gastrointestinal disease, and liver function test abnormalities in adult females.

Did you get that?

The Hepatitis B vaccine is statistically associated with increased risk for hepatitis in adults!

A more recent study in June 2011 reported by the journal Molecular Biology Reports indicates that damage from Hep B is likely caused by alteration in the expression of 144 genes in mouse livers within one day of vaccination, 7 of which are associated with inflammation and metabolism.

The Only Sane Answer is Rejection of the Hepatitis B Vaccine

To date, 50+ negative health effects from the Hepatitis B vaccine have been documented in peer-reviewed, published literature.

The thing that makes absolutely zero sense is why the controversial and very questionable Hepatitis B vaccine is still being recommended as standard for all newborns within hours of birth especially given that a newborn’s liver does not even begin functioning until several days later.

With no functioning liver to assist with detoxification, the damaging effects of the toxic Hep B ingredients would no doubt be magnified with the risk of irreparable harm to the newborn great.

If you are a parent with a baby on the way, please do your research and learn the extreme danger of the Hepatitis B vaccine to your newborn.

Even if you have been supportive of vaccination in the past, at least skip this one controversial shot that has so much documented literature about its damaging effects.

There is simply no logical reason to vaccinate all newborns against a disease that is primarily sexually transmitted or contracted via the used needles of drug addicts.  Better to screen mothers preemptively rather than vaccinate all newborns with this dangerous drug cocktail that threatens their long term health.
Contact Information 
EVDN Homepage

Mar 10, 2013

Flu Shot Adjuvant AS03 Linked to Narcolepsy: 800 Kids Affected

Via EV
 George Carlin said, “They call it the American Dream because you have to be asleep to believe it”. The New World orders medication junkies have come up with a new concoction they hope to inject into your body that will ensure you get a full dose of the American dream. GlaxoSmithKline's Pandemrix vaccine was created for the 2009 H1N1 flu pandemic sensationalized by the propagating pundits and media whores on lamestream teliesvision.  
 In Sweden last year 50 children were overcome with a sleeping disorder called narcolepsy after receiving their annual flu vaccination. As of this year across Europe over 800 children have now been affected with this rare sleeping disorder. A new study indicates a direct link between one of the vaccine adjuvants and the growing number of narcolepsy cases being reported in kids. The industry claim that the main reason for adding these adjuvants is for the sole purpose of turbocharging the potency of the vaccine in order to boost the body's immune response to it.  The AS03 adjuvant being used in the Pandemrix vaccine is the primary suspect responsible for putting children to sleep via the use of this neurological toxin contained in the vaccinators lancet.
Despite this information the vaccine industry continue to sell the Pandemrix flu vaccine to adults though out Europe. The New World orders pharmacratical dictators seek to medicate you into discomfort and vaccinated you into disorder. The ultimate goal is to make sure that people become patients and being alive becomes a diagnosis. Vaccines are designed to weaken and damage your immune system making you more susceptible to these diseases when you encounter them in the wild.
Welcome to a Brave New World!

Via: NBC News
LONDON — Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients, AS03, under intense scrutiny.

The ingredient is one of a class of pharmaceuticals known as adjuvants, or boosters, designed to turbo charge the potency of a vaccine and the body's immune response to it.

AS03 was widely used in Europe during the 2009-2010 H1N1 flu pandemic and is also contained in a GSK adjuvanted flu vaccine which in November last year became the first of its kind to be recommended for approval by the normally adjuvant-wary United States Food and Drug Administration (FDA).

There's little doubt AS03 does its job well.

Don't miss these Health stories

Flu season hitting elderly hard, CDC says
This year’s especially grim flu season has been sickening and killing a very high number of people over 65, federal officials report. And doctors reported flu killed 14 kids last week, bringing the total childhood deaths to 59.

Aging bikers 3 times more likely to get injured
Millennials are the most stressed-out generation
Too much TV may hurt his fertility
Boomers aging worse than past generation
Pandemrix, the flu vaccine under suspicion for the narcolepsy link, needs only a fraction of the antigen - the part that actually does the immunization - of other flu shots to give sufficient protection.

This means the manufacturer - in this case GSK - can produce multiple times the number of vaccine doses without needing to spend valuable time making large amounts of the antigen.

In a pandemic situation in which the lives of millions around the world are under threat, that could make the difference between having enough vaccines to protect entire populations, or having to decide how to ration them out.

Yet some experts believe the turbo-charged immune response AS03 generates, or the ingredients that drive it, may also be the answer to why almost 800 cases of the incurable sleeping disorder narcolepsy have been linked to Pandemrix's use in Europe during the 2009/2010 H1N1 pandemic.

"The adjuvant in the Pandemrix vaccine is very potent and we think it may have played a role," says Markku Partinen, a neurologist at the Helsinki Sleep Clinic in Finland who has spent the past few years investigating what might be behind the link between the vaccine and narcolepsy.

If it is the reason for the spike in the disease, Partinen and other researchers think it may be because the adjuvant's strength boosted not just a good immune response but possibly an adverse one too.

Partinen was one of the first scientists to pick up a signal that something might be going awry in children in Finland vaccinated with Pandemrix in a nationwide immunization campaign against the H1N1 flu.

Since then studies in Sweden, Finland, Ireland and now Britain have found the risk of developing narcolepsy is between seven and 13 times higher in children who were immunized with Pandemrix than in those who were not.

Among the 800 cases of Pandemrix-related narcolepsy reported so far across Europe, many are children who say the life-long and incurable disease has all but wrecked normal life.

Narcolepsy's most common symptoms are bouts of daytime sleepiness, but in its severe forms it also brings nightmares, hallucinations, sleep paralysis and cataplexies - when strong emotions trigger a sudden loss of muscle strength.

Doctors and researchers who have been treating and analyzing cases of Pandemrix-linked narcolepsy say a common feature is that quite severe symptoms come on abruptly in these patients.

Pandemrix's maker GlaxoSmithKline says it accepts the evidence of a statistical link but wants to see more research into whether the vaccine or any of its ingredients are implicated in actually causing narcolepsy.

"There is absolutely no doubt that people vaccinated with our vaccine were shown in published studies to be more likely to develop narcolepsy than people who were not. As a statistical association that's clear. It's a very different thing, though, to say that then means A causes B," said Norman Begg, chief medical officer at GSK's vaccines division.

Regulators - both those at the European Medicine's Agency (EMA) which licenses Pandemrix, and those at the FDA whose advisory panel recently recommended approval of a GSK pandemic vaccine with the same adjuvant - say that for now suspicions about AS03 remain just that and offer no reason to put a stop to its use.

"There are so many theories behind what is happening here," said Tomas Salmonson, who is both an official at the Swedish Medicines Agency and head of EMA's Committee for Medicinal Products for Human Use, which advises on drugs' safety and efficacy.

FDA spokeswoman Rita Chappelle said the regulator could not discuss Pandemrix since it is not licensed in the United States. Asked about the GSK pandemic vaccine containing the same adjuvant which the FDA has been advised to recommend, she said the FDA evaluates each drug license application "based on the merits of the safety and efficacy data submitted".

After being instructed by the EMA to investigate further, GSK is conducting a study in Canada where around 2 million doses of a GSK vaccine called Arepanrix - very similar to Pandemrix and containing the same AS03 adjuvant - were used to immunize children during the H1N1 pandemic.

"Narcolepsy has a number of different potential contributory factors," Begg said. "Disentangling those potential confounding variables is something that really hasn't yet been done."

Independent groups of researchers around the world working hard to do that are homing in on AS03 and its super immune response boosting capability.

The adjuvant is not a single ingredient, but a combination of three - squalene, an oil derived from shark livers, a form of vitamin E called DL-alpha-tocopherol, and an emulsifier, or mixing agent, called polysorbate 80.

Both the squalene and the vitamin E are there to boost the response of the immune system to the H1N1 antigen - the molecule the immune system needs to learn to recognize in order to protect against infection in future.

At Stanford University in the United States, professor of psychiatry and narcolepsy expert Emmanuel Mignot believes the mistake may have been in putting the H1N1 virus, which itself produces a strong immune response and is used in the vaccine, together with such a potent booster combination.

"It's clear that H1N1 is a key ingredient. But it's also clear that if you didn't have the adjuvant you also didn't have this dramatically increased risk (of developing narcolepsy)," said Mignot, who is being funded by GSK to conduct further research into the links.

"So my opinion is that it was a combination of both in Pandemrix that made it very nasty for narcolepsy."

Asked about the questions surrounding AS03 and Pandemrix at a briefing for journalists in London this week, GSK's chief executive Andrew Witty said his firm is exploring all avenues but is unlikely to be able to come to a conclusion soon.

"We are all over terms of trying to help figure out what's going on here," he said. "We're taking it very seriously and we're focused on trying to understand any link there is and come to a conclusion as soon as we can. I think it's equally important we don't rush to the wrong conclusion."

While narcolepsy is a mysterious disease with some uncertainty about its precise cause, the consensus view among scientists is that it is an autoimmune disorder - one in which the immune system is stimulated to attack the body's own cells.

Narcolepsy patients have low levels of a neurotransmitter called hypocretin, which regulates wakefulness, and scientists believe this deficit is most likely due to hypocretin-containing cells being destroyed by an autoimmune attack.

Because both narcolepsy and vaccines are linked to the function of the immune system, the biological plausibility of a link between the disorder and a vaccine with such an effective adjuvant has a sound scientific basis, says Outi Vaarala of the Immune Response Unit at Finland's National Institute for Health and Welfare, who has been studying links between narcolepsy and Pandemrix since cases appeared there in 2010.

Narcolepsy is also strongly linked to a variant in a gene called HLA, which controls the function of a subtype of white blood cells. White blood cells are key to the immune system and experts say this link underpins the theory that narcolepsy is most likely an autoimmune disease.

Around 25 percent of people in northern and central Europe are thought to have the HLA genetic vulnerability to narcolepsy, with a lower percentage in southern European countries.

Vaarala is investigating the details of the vaccine's ingredients and, like others, thinks the answer may lie in the way certain children's immune systems responded to the antigen and then had that response supercharged by AS03.

Vaarala's studies also raise questions over whether GSK's own investigations, which are centered on use of Arepanrix in Canada, may turn out to be a something of a red herring.

There is no evidence so far of increases in narcolepsy cases in children in Canada. While this could reflect variables like differences in the genetic makeup of those vaccinated, or the timing of when they got their shots during the pandemic, some believe the answer may lie tiny differences between the Arepanrix and Pandemrix vaccines.

Ingredients lists for Pandemrix and Arepanrix show the two vaccines have the same antigen and the same adjuvant, but GSK's Begg says the two products have some "minor formulation differences" because they were manufactured at different sites.

Pandemrix was made in at a manufacturing plant in Dresden, Germany, while Arepanrix was made at one in Quebec, Canada.

In studies she has yet to submit for peer review and publication, Vaarala says she has found differences in the way antibodies from Pandemrix-vaccinated children bind to the virus antigen in the Dresden-made shot and the way they do in the Canadian-made version.

"Our findings of the immunological differences between Pandemrix and Arepanrix virus antigen are important clues to the mechanism of Pandemrix-related narcolepsy," she told Reuters.

GSK says it is exploring all aspects of the issue, but says that for now it has seen no indication that the manufacturing process for Pandemrix is involved.

Although Pandemrix is no longer recommended for use in children and adolescents under 20, it is still licensed for use in Europe in immunizing adults against H1N1.

The EMA's Salmonson notes the many unanswered questions surrounding AS03, but says it would be wrong to halt its use until scientists know more.

"We may speculate that this specific antigen together with a very potent adjuvant could be the cause for all this. But that's only one of several possible explanations," he said. "The fact that we today do not understand the underlying mechanism shows how complex this is."
Contact Links